BioCentury | Nov 20, 2020
Finance
SR One’s newfound freedom allows firm to increase focus on company creation
SR One’s spinout from GSK gives the newly independent VC the ability to scale up what has been a top-tier investment firm over the past decade, along with the freedom to take larger stakes...